Literature DB >> 18381783

Identification of cytokines that might enhance the promoter activity of HLA-B27.

Like Zhao1, Yoly Fong, Kaisa Granfors, Jieruo Gu, David Yu.   

Abstract

OBJECTIVE: Although the mechanism by which HLA-B27 induces ankylosing spondylitis is unclear, a minimum threshold of transcription is essential, a process controlled at the promoter. Our aim was to scan the effect of a panel of cytokines on the promoter of the HLA-B27 gene over serial timepoints.
METHODS: The promoter region of B*2705 gene was cloned into a luciferase reporter, stably transfected into HeLa cells, and used to monitor the serial effect of 25 cytokines. Results of HLA-B27 promoter-reporter assays were compared to those of real-time polymerase chain reactions.
RESULTS: After an initial delay, significant activation of the HLA-B27 promoter was observed with tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), and IFN-beta. While early response of the HLA-B27 promoter was highest with TNF-alpha and IFN-gamma, ultimately the highest activity was observed with IFN-beta.
CONCLUSION: The only promoter of HLA-B alleles studied in the past was that of HLA-B7, and always at only a single fixed timepoint of culture. This is the first study to show that activation of HLA-B27 promoter is a sequential event, and that TNF-alpha and IFN-beta are major participants at different timepoints.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381783

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Decreased A20 expression on circulating CD56bright NK cells contributes to a worse disease status in patients with ankylosing spondylitis.

Authors:  M Yang; Y Zhou; L Liu; S Wang; J Jiang; Q Shang; H Yu; X Xiang; X Pang; T Li; P Zhao
Journal:  Clin Exp Immunol       Date:  2019-06-30       Impact factor: 4.330

Review 2.  Pathogenesis of ankylosing spondylitis.

Authors:  Lai-Shan Tam; Jieruo Gu; David Yu
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

3.  Identification of RGS1 as a candidate biomarker for undifferentiated spondylarthritis by genome-wide expression profiling and real-time polymerase chain reaction.

Authors:  Jieruo Gu; Yu-Ling Wei; James C C Wei; Feng Huang; Ming-Shiou Jan; Michael Centola; Mark B Frank; David Yu
Journal:  Arthritis Rheum       Date:  2009-11

4.  All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study.

Authors:  Deng Li; Peng Wang; Yuxi Li; Zhongyu Xie; Le Wang; Hongjun Su; Wen Deng; Yanfeng Wu; Huiyong Shen
Journal:  Stem Cells Int       Date:  2015-06-01       Impact factor: 5.443

5.  Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis.

Authors:  Jose Ramon Maneiro; Alejandro Souto; Eva Salgado; Antonio Mera; Juan J Gomez-Reino
Journal:  RMD Open       Date:  2015-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.